New Insights on DR and DQ Human Leukocyte Antigens in Anti-LGI1 Encephalitis.
Journal
Neurology(R) neuroimmunology & neuroinflammation
ISSN: 2332-7812
Titre abrégé: Neurol Neuroimmunol Neuroinflamm
Pays: United States
ID NLM: 101636388
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
16
08
2022
accepted:
26
01
2023
medline:
29
3
2023
entrez:
27
3
2023
pubmed:
28
3
2023
Statut:
epublish
Résumé
To explore the clinical characteristics and HLA associations of patients with anti-leucine-rich glioma-inactivated 1 encephalitis (LGI1E) from a large single center in Israel. Anti-LGI1E is the most commonly diagnosed antibody-associated encephalitic syndrome in adults. Recent studies of various populations reveal significant associations with specific HLA genes. We examined the clinical characteristics and HLA associations of a cohort of Israeli patients. Seventeen consecutive patients with anti-LGI1E diagnosed at Tel Aviv Medical Center between the years 2011 and 2018 were included. HLA typing was performed using next-generation sequencing at the tissue typing laboratory of Sheba Medical Center and compared with data from the Ezer Mizion Bone Marrow Donor Registry, containing over 1,000,000 samples. Our cohort displayed a male predominance and median age at onset in the 7th decade, as previously reported. The most common presenting symptom was seizures. Notably, paroxysmal dizziness spells were significantly more common than previously reported (35%), whereas faciobrachial dystonic seizures were found only in 23%. HLA analysis revealed overrepresentation of DRB1*07:01 (OR: 3.18, CI: 20.9 Our cohort presents distinct immune characteristics with substantially higher overrepresentation of DRB1*04:02 and slightly lower overrepresentation of DQB1*07:01 compared with previous reports implying differences between different populations. DQ-DR interactions found in our cohort may shed additional light on the complex role of immunogenetics in the pathogenesis of anti-LGI1E, implying a possible relevance of certain DQ alleles and DR-DQ interactions.
Sections du résumé
BACKGROUND AND OBJECTIVES
To explore the clinical characteristics and HLA associations of patients with anti-leucine-rich glioma-inactivated 1 encephalitis (LGI1E) from a large single center in Israel. Anti-LGI1E is the most commonly diagnosed antibody-associated encephalitic syndrome in adults. Recent studies of various populations reveal significant associations with specific HLA genes. We examined the clinical characteristics and HLA associations of a cohort of Israeli patients.
METHODS
Seventeen consecutive patients with anti-LGI1E diagnosed at Tel Aviv Medical Center between the years 2011 and 2018 were included. HLA typing was performed using next-generation sequencing at the tissue typing laboratory of Sheba Medical Center and compared with data from the Ezer Mizion Bone Marrow Donor Registry, containing over 1,000,000 samples.
RESULTS
Our cohort displayed a male predominance and median age at onset in the 7th decade, as previously reported. The most common presenting symptom was seizures. Notably, paroxysmal dizziness spells were significantly more common than previously reported (35%), whereas faciobrachial dystonic seizures were found only in 23%. HLA analysis revealed overrepresentation of DRB1*07:01 (OR: 3.18, CI: 20.9
DISCUSSION
Our cohort presents distinct immune characteristics with substantially higher overrepresentation of DRB1*04:02 and slightly lower overrepresentation of DQB1*07:01 compared with previous reports implying differences between different populations. DQ-DR interactions found in our cohort may shed additional light on the complex role of immunogenetics in the pathogenesis of anti-LGI1E, implying a possible relevance of certain DQ alleles and DR-DQ interactions.
Identifiants
pubmed: 36973076
pii: 10/3/e200103
doi: 10.1212/NXI.0000000000200103
pmc: PMC10042442
pii:
doi:
Substances chimiques
HLA-DQ Antigens
0
HLA-DQ beta-Chains
0
HLA-DRB1 Chains
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Références
Curr Opin Immunol. 2014 Dec;31:24-30
pubmed: 25216261
BMC Bioinformatics. 2010 Nov 22;11:568
pubmed: 21092157
Tissue Antigens. 1996 Feb;47(2):127-33
pubmed: 8851726
Hum Immunol. 2021 Oct;82(10):746-757
pubmed: 34325951
Nature. 2011 Aug 10;476(7359):214-9
pubmed: 21833088
J Neuroimmunol. 2020 Jul 15;344:577243
pubmed: 32417596
Ann Neurol. 2017 Feb;81(2):193-198
pubmed: 28026046
Autoimmunity. 2006 Jun;39(4):277-88
pubmed: 16891216
Brain. 2010 Sep;133(9):2734-48
pubmed: 20663977
Neurol Neuroimmunol Neuroinflamm. 2021 Mar 5;8(3):
pubmed: 33848259
J Biol Chem. 2010 Dec 24;285(52):40800-8
pubmed: 20959457
Bioinformatics. 2019 Sep 15;35(18):3520-3523
pubmed: 30689784
Brain. 2018 Aug 1;141(8):2263-2271
pubmed: 29788256
Neurology. 2011 Apr 12;76(15):1355-7
pubmed: 21482953
Ann Neurol. 2011 May;69(5):892-900
pubmed: 21416487
J Proteome Res. 2020 Jun 5;19(6):2304-2315
pubmed: 32308001
Brain. 2020 Jun 1;143(6):1731-1745
pubmed: 32437528
J Immunol. 2002 Dec 15;169(12):6928-34
pubmed: 12471126
Ann Neurol. 2018 Apr;83(4):863-869
pubmed: 29572931
Neurobiol Dis. 2021 Dec;160:105537
pubmed: 34695575
Neurology. 2016 Oct 4;87(14):1449-1456
pubmed: 27590293
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7542-7
pubmed: 19380721
Eur J Neurol. 2022 Aug;29(8):2367-2375
pubmed: 35488492
Hum Immunol. 2001 Jan;62(1):85-91
pubmed: 11165718
Lancet Neurol. 2010 Aug;9(8):776-85
pubmed: 20580615
Neurology. 2016 Aug 23;87(8):759-65
pubmed: 27466467
Ann Neurol. 2012 Dec;72(6):927-35
pubmed: 23055271
Ann Neurol. 2017 Feb;81(2):183-192
pubmed: 28026029
N Engl J Med. 2009 Apr 16;360(16):1646-54
pubmed: 19369670
Arch Neurol. 1999 May;56(5):555-60
pubmed: 10328250
Neurol Neuroimmunol Neuroinflamm. 2022 Feb 3;9(2):
pubmed: 35115410
Clin Gastroenterol Hepatol. 2004 Oct;2(10):888-94
pubmed: 15476152
Epilepsia. 2022 Mar;63(3):709-722
pubmed: 35032032
J Clin Invest. 2002 Apr;109(8):1111-20
pubmed: 11956249
Tissue Antigens. 2003 Oct;62(4):296-307
pubmed: 12974796
Front Immunol. 2021 Jan 29;11:605214
pubmed: 33584677
Ann Neurol. 2020 Mar;87(3):405-418
pubmed: 31900946
Brain. 2018 Feb 1;141(2):348-356
pubmed: 29272336
Hum Immunol. 2000 Mar;61(3):279-89
pubmed: 10689117
Neuropsychiatr Dis Treat. 2021 Jan 25;17:203-212
pubmed: 33531809
Ann Neurol. 2017 Jul;82(1):79-92
pubmed: 28628235